Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

IKNA

Ikena Oncology Inc

May 17 • 10:47AM ET

1.37

Dollar change -0.03
Percentage change -2.14	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO IWC VTWV URTY UWM HDG

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.58	Insider Own	47.40%	Shs Outstand	48.26M	Perf Week	6.20%
Market Cap	66.12M	Forward P/E	-	EPS next Y	-1.22	Insider Trans	0.00%	Shs Float	25.38M	Perf Month	8.73%
Income	-70.09M	PEG	-	EPS next Q	-0.34	Inst Own	30.10%	Short Float	5.97%	Perf Quarter	0.00%
Sales	3.85M	P/S	17.17	EPS this Y	15.95%	Inst Trans	-1.41%	Short Ratio	4.21	Perf Half Y	-2.14%
Book/sh	3.22	P/B	0.43	EPS next Y	10.95%	ROA	-43.11%	Short Interest	1.52M	Perf Year	-78.86%
Cash/sh	3.26	P/C	0.42	EPS next 5Y	-	ROE	-48.28%	52W Range	1.02 - 7.38	Perf YTD	-30.46%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-7.46%	ROI	-43.36%	52W High	-81.44%	Beta	0.38
Dividend TTM	-	Quick Ratio	15.85	Sales past 5Y	280.42%	Gross Margin	64.86%	52W Low	34.31%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	15.85	EPS Y/Y TTM	13.62%	Oper. Margin	-1963.23%	RSI (14)	52.98	Volatility	5.45% 5.97%
Employees	43	Debt/Eq	0.06	Sales Y/Y TTM	-78.07%	Profit Margin	-1821.54%	Recom	1.00	Target Price	9.50
Option/Short	No / Yes	LT Debt/Eq	0.04	EPS Q/Q	14.69%	Payout	-	Rel Volume	0.35	Prev Close	1.40
Sales Surprise	-100.00%	EPS Surprise	17.02%	Sales Q/Q	-100.00%	Earnings	May 13 AMC	Avg Volume	360.42K	Price	1.37
SMA20	3.07%	SMA50	-0.23%	SMA200	-45.06%	Trades		Volume	29,635	Change	-2.14%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-22-23	Initiated	Wedbush	Outperform	$11
May-04-23	Resumed	H.C. Wainwright	Buy	$18
Dec-23-21	Initiated	H.C. Wainwright	Buy	$25
May-05-21	Resumed	Credit Suisse	Outperform	$30
Apr-26-21	Resumed	Credit Suisse	Outperform	$30
Apr-20-21	Initiated	William Blair	Outperform
Apr-20-21	Initiated	Jefferies	Buy
Apr-20-21	Initiated	Credit Suisse	Outperform	$30

May-13-24 08:52PM	IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024 (InvestorPlace)
04:45PM	Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update (GlobeNewswire)
Apr-10-24 08:00AM	Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum (GlobeNewswire) -5.26%
Mar-12-24 08:00AM	Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-27-24 08:00AM	Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
04:15PM	Loading…
Feb-21-24 04:15PM	Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer (GlobeNewswire)
Feb-14-24 09:35AM	Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround (Zacks)
Jan-24-24 09:35AM	Down -33.01% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround (Zacks)
Jan-19-24 06:25AM	Ikena Oncology to lay off 35% of staff (BioPharma Dive) -7.32%
Jan-18-24 04:05PM	Ikena Oncology Outlines Key Priorities and Provides Corporate Updates (GlobeNewswire) -5.20%
Nov-09-23 07:00AM	Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results (GlobeNewswire) -67.80%
Nov-07-23 08:00AM	Ikena Oncology to Present at Multiple November 2023 Investor Conferences (GlobeNewswire)
Sep-27-23 09:01AM	Pliant Therapeutics, Inc. (PLRX) Soars 14.3%: Is Further Upside Left in the Stock? (Zacks)
Sep-05-23 08:00AM	Ikena Oncology to Participate in September 2023 Investor Conferences (GlobeNewswire)
Aug-12-23 08:07AM	Downgrade: Here's How Analysts See Ikena Oncology, Inc. (NASDAQ:IKNA) Performing In The Near Term (Simply Wall St.)
09:30AM	Loading…
Aug-10-23 09:30AM	Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +8.10%
08:00AM	Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update (GlobeNewswire)
06:08AM	The Petri Dish: Agios licenses Alnylam drug, Ikena acquires startup with Gilead stake (American City Business Journals)
Aug-08-23 08:24AM	Loss-making Ikena Oncology (NASDAQ:IKNA) sheds a further US$11m, taking total shareholder losses to 22% over 1 year (Simply Wall St.)
Aug-07-23 07:00AM	Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction (GlobeNewswire) -7.51%
Jun-20-23 08:50AM	Recent Price Trend in Ikena Oncology, Inc. (IKNA) is Your Friend, Here's Why (Zacks)
Jun-05-23 02:59PM	We're Keeping An Eye On Ikena Oncology's (NASDAQ:IKNA) Cash Burn Rate (Simply Wall St.)
Jun-02-23 08:50AM	Ikena Oncology, Inc. (IKNA) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-24-23 08:00AM	Ikena Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-16-23 08:29AM	Party Time: Brokers Just Made Major Increases To Their Ikena Oncology, Inc. (NASDAQ:IKNA) Earnings Forecasts (Simply Wall St.) -12.00%
May-15-23 09:05AM	Ikena Oncology, Inc. (IKNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:50AM	Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology Pipeline (GlobeNewswire)
07:45AM	Ikena Oncology Announces $40 Million Underwritten Offering (GlobeNewswire)
06:01AM	Ikena Oncology, Inc.'s (NASDAQ:IKNA) largest shareholders are private equity firms with 46% ownership, institutions own 31% (Simply Wall St.)
May-10-23 05:35PM	Kronos Bio, Inc. (KRON) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:42AM	Loading…
08:42AM	Why Ikena Oncology (IKNA) Might Surprise This Earnings Season (Zacks)
May-08-23 12:07PM	Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing? (Zacks)
May-04-23 09:00PM	Ikena Oncology, Inc. (IKNA) Stock Jumps 7.9%: Will It Continue to Soar? (Zacks) +7.90%
May-03-23 08:50AM	Here's Why Momentum in Ikena Oncology, Inc. (IKNA) Should Keep going (Zacks)
May-02-23 09:29PM	Immatics (IMTX) Moves 27.5% Higher: Will This Strength Last? (Zacks)
Apr-20-23 08:00AM	Ikena Oncology to Participate in the Stifel 2023 Virtual Targeted Oncology Days (GlobeNewswire) -5.22%
Apr-17-23 09:00AM	Ikena Oncology Shares Differentiation Profile of IK-930, a Novel Hippo-Pathway Inhibitor, Including Projected Therapeutic Index Advantages and Breadth of Patient Populations at AACR 2023 Annual Meeting (GlobeNewswire)
06:48AM	Getting In Cheap On Ikena Oncology, Inc. (NASDAQ:IKNA) Is Unlikely (Simply Wall St.)
Mar-14-23 08:15AM	Ikena Oncology, Inc. (IKNA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Ikena Oncology Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-07-23 08:00AM	Ikena Oncology Presents Preclinical Data on IK-595, Best-in-Class Next-Generation MEK-RAF Complex Inhibitor, in Plenary Session at AACR Special Conference on RAS Targeting (GlobeNewswire) +12.95%
Mar-06-23 08:00AM	Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma (GlobeNewswire)
Mar-01-23 07:13AM	Ikena Oncology (NASDAQ:IKNA) shareholders have endured a 43% loss from investing in the stock a year ago (Simply Wall St.)
Feb-28-23 08:00AM	Ikena Oncology to Participate in Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Dec-22-22 07:13AM	Is Ikena Oncology (NASDAQ:IKNA) In A Good Position To Invest In Growth? (Simply Wall St.)
Dec-19-22 04:30PM	Ikena Oncology Appoints Owen Hughes as Board Chair (GlobeNewswire)
Nov-28-22 12:11PM	Ikena Oncology Announces New Cancer Program, Shelves Early Asset For Colorectal Cancer (Benzinga)
08:00AM	Ikena Oncology Announces New Program in Next-Generation MEK-RAF Inhibition and Provides Corporate Update (GlobeNewswire)
Nov-22-22 07:30AM	Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire) +5.45%
Nov-11-22 10:05AM	Ikena Oncology Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-10-22 09:00AM	Ikena Oncology Announces Initial Clinical Data from IK-175 Program in Urothelial Carcinoma (GlobeNewswire)
Nov-07-22 09:25AM	Ikena Oncology, Inc. (IKNA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:48AM	UPDATE -- Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update (GlobeNewswire)
08:05AM	Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update (GlobeNewswire)
Oct-26-22 07:30AM	Ikena Oncology Presents Preclinical Data at the 34th EORTC-NCI-AACR Symposium on Novel TEAD Inhibitor, IK-930, Combating Therapeutic Resistance (GlobeNewswire) +6.97%
Oct-18-22 07:30AM	Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway (GlobeNewswire)
Oct-05-22 08:05AM	Ikena Oncology to Present Initial Phase 1a/b Results from Novel AHR Inhibition Program at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (GlobeNewswire) -9.73%
Sep-22-22 06:25AM	Investors one-year losses grow to 71% as the stock sheds US$33m this past week (Simply Wall St.) -8.95%
Sep-06-22 07:30AM	Ikena Oncology to Participate in September 2022 Investor Conferences (GlobeNewswire)
Aug-12-22 07:41AM	Analysts Just Slashed Their Ikena Oncology, Inc. (NASDAQ:IKNA) EPS Numbers (Simply Wall St.)
Aug-11-22 08:45AM	Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Ikena Oncology Reports Second Quarter 2022 Financial Results and Provides a Corporate Update (GlobeNewswire)
Jul-14-22 10:43AM	How Much Of Ikena Oncology, Inc. (NASDAQ:IKNA) Do Institutions Own? (Simply Wall St.)
Jul-06-22 07:00AM	Ikena Oncology to Participate in the William Blair Biotech Focus Conference 2022 (GlobeNewswire) +6.38%
Jun-22-22 07:00AM	Ikena Oncology Receives FDA Fast Track Designation for Novel TEAD Inhibitor IK-930 to Treat Unresectable NF2-Deficient Mesothelioma (GlobeNewswire) +5.48%
Jun-14-22 09:13AM	We Think Ikena Oncology (NASDAQ:IKNA) Can Afford To Drive Business Growth (Simply Wall St.)
May-18-22 07:00AM	Ikena Oncology to Participate in Spring 2022 Investor Conferences (GlobeNewswire) -7.23%
May-15-22 08:41AM	Ikena Oncology, Inc. (NASDAQ:IKNA) Just Reported Earnings, And Analysts Cut Their Target Price (Simply Wall St.)
May-13-22 08:28AM	The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma (Zacks)
May-12-22 08:35AM	Ikena Oncology, Inc. (IKNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Ikena Oncology Reports First Quarter 2022 Financial Results and Provides a Corporate Update (GlobeNewswire)
May-11-22 08:44AM	Is a Surprise Coming for Ikena Oncology (IKNA) This Earnings Season? (Zacks) -16.00%
07:32AM	5 Biotech Stocks Set to Outpace Q1 Earnings Estimates (Zacks)
May-02-22 07:00AM	Ikena Oncology and Vall dHebron Institute of Oncology Announce Research & Development Collaboration (GlobeNewswire)
Apr-28-22 07:00AM	Ikena Oncology to Present at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting (GlobeNewswire) -10.49%
Apr-13-22 07:00AM	Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer and Head of Corporate Development (GlobeNewswire) +7.35%
Apr-12-22 02:01PM	10 Best Micro-Cap Stocks to Buy According to Hedge Funds (Insider Monkey)
Mar-28-22 05:37PM	Ikena Oncology (NASDAQ:IKNA shareholders incur further losses as stock declines 16% this week, taking one-year losses to 79% (Simply Wall St.)
Mar-17-22 07:00AM	Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update (GlobeNewswire) +23.30%
Mar-07-22 04:30PM	Ikena Oncology to Present Preclinical Findings on IK-930, a Novel TEAD Inhibitor at the 2022 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Mar-01-22 07:00AM	Ikena Oncology to Participate in Cowen 42nd Annual Health Care Conference (GlobeNewswire)
Feb-03-22 04:35PM	Top 10 Stock Picks of Samuel Isalys OrbiMed Advisors (Insider Monkey) -14.76%
Jan-26-22 07:00AM	Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors (GlobeNewswire)
Dec-24-21 12:38AM	Orbimed Advisors Llc Buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, ... (GuruFocus.com)
Dec-23-21 06:05AM	Here's Why We're Not Too Worried About Ikena Oncology's (NASDAQ:IKNA) Cash Burn Situation (Simply Wall St.)
Dec-18-21 12:38AM	Orbimed Advisors Llc Buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, ... (GuruFocus.com)
Dec-17-21 08:00AM	Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies (PR Newswire) -5.61%
Dec-08-21 07:00AM	Ikena Appoints Michelle Zhang, Ph.D., Industry and Company Veteran, as Chief Scientific Officer (GlobeNewswire) +13.73%
Nov-12-21 07:00AM	Ikena Oncology Presents Data at SITC 36th Annual Meeting Describing the Indication Selection Methodology, Translational Data, and Trial in Progress for IK-175 (GlobeNewswire)
Nov-10-21 07:00AM	Ikena Oncology Reports Third Quarter 2021 Financial Results and Corporate Update (GlobeNewswire) +10.94%
Nov-04-21 07:00AM	Ikena Oncology to Participate in November 2021 Virtual Investor Conferences (GlobeNewswire)
Nov-02-21 08:00AM	Ikena Oncology Announces FDA Acceptance of IND Application of Novel TEAD Inhibitor IK-930 (GlobeNewswire) +8.93%
Oct-07-21 09:00AM	Ikena Oncology Presents Data at AACR-NCI-EORTC Virtual Conference Demonstrating Potential of TEAD Inhibitors in Cancer Treatment (GlobeNewswire) +9.21%
Oct-01-21 08:15AM	Ikena Oncology to Present a Trial-in-Progress Update, Translational Data, and Indication Selection Methodology for Novel AHR Inhibition Program at the 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting (GlobeNewswire)
Sep-02-21 07:00AM	Ikena Oncology to Participate in September 2021 Virtual Investor Conferences (GlobeNewswire)
Aug-12-21 07:00AM	Ikena Oncology Reports Second Quarter 2021 Financial Results and Provides Update on Key Programs (GlobeNewswire) +7.50%
Jul-08-21 07:00AM	Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021 (GlobeNewswire)
Jun-26-21 05:18AM	Companies Like Ikena Oncology (NASDAQ:IKNA) Are In A Position To Invest In Growth (Simply Wall St.)
May-26-21 07:00AM	Ikena Oncology to Participate in the 2021 Jefferies Virtual Healthcare Conference (Business Wire)
May-13-21 07:00AM	Ikena Oncology Reports First Quarter 2021 Financial Results and Outlines Key Corporate Objectives for 2021 (Business Wire) -13.61%

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IKNA

Ikena Oncology Inc

Upgrade your FINVIZ experience